The case for & against
Bull & Bear analysis
Bullish
American Shared Hospital Services (AMS) operates in the healthcare sector with a focus on providing innovative radiation therapy solutions and transitioning from a traditional medical equipment leasing model to direct patient care services. The company has established a solid market position through its strategic partnerships with hospitals and medical institutions. As AMS invests in expanding its operational footprint both domestically and internationally, including places like Mexico and Rhode Island, it positions itself within the larger trend of increasingly patient-centric healthcare services.
Bull says
- ↑Q3 revenue $7.2M (+2.5% YoY) with 56% from direct patient care
- ↑Puebla, Mexico center achieved 263% annual revenue growth in first year
- ↑Gross margin improved to 22.1% from 20.4% YoY, boosting profitability
- ↑Direct services revenue rose 9.4% YoY to $4M, indicating strong adoption
- ↑New proton therapy center in Rhode Island on track for 2027 opening
- ↑Strong book-to-price ratio (0.6682) and 0.93% dividend yield support valuation
Bear says
- ↓Equipment leasing revenue declined 33.9% to $2.9M in Q4 2025 on contract expirations
- ↓Full-year net loss of $1.6M vs. $2.2M profit prior year signals profitability risks
- ↓Cash and equivalents dropped to $3.7M after $7.5M capex, pressuring liquidity
- ↓Physician turnover and shifting reimbursement dynamics risk operational execution
- ↓Negative earnings yield and weak profitability factors suggest return challenges
- ↓High volatility profile may drive share price swings and investor caution
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 08-18-2026bullish
Transcript signals
Bull points
- For the second quarter ended June 30, 2025, total revenue increased 16% to $7.1 million
- Revenue from our direct patient services segment was 3.5 million for Q2 2025, compared to 3.1 million in Q2 2024, marking an increase of 12%. This growth was primarily driven by the acquisition of a majority interest in the Rhode Island radiation therapy operations in Q2 2024, and the launch of operations in Pueblo, Mexico in the second half of 2024.
- For the first half of 2025, total revenue increased 7%, to $13.2 million compared to $12.3 million in the first half of 2024. Revenue from our direct patient care services segment was $6.6 million for the first half of 2025 compared to $4.1 million in the first half of 2024, marking an increase of 61%. This significant growth was primarily driven by the acquisition of the Rhode Island Radiation Therapy Operations in Q2 2024 and the launch of operations in Pueblo, Mexico in the second half of 2024.
Bear points
- Q2 2025 operating income was a loss of $544,000 compared to a loss of $1.3 million in Q1 2025 and a loss of $1,000 in Q2 2024.
- Gamma knife revenue declined 11.4% to $4.7 million for the first half of 2025 compared to $5.3 million in the first half of 2024. The number of gamma knife procedures in the first half of 2025 was 472. a 23% decrease from 613 procedures in the first half of 2024. This decline was primarily due to the expiration of two contracts in December 2024 and April 2025, and downtime to upgrade a third customer to newer technology.
- Net loss attributed to the American share of hospital services for the first half of 2025 was $905,000, or 14 cents, per diluted share compared to net income of 3.7 million or 57 cents per diluted share for the first half of 2024.
Read full transcript analysis ›